Skip to main content
Premium Trial:

Request an Annual Quote

Bristol Myers-Squibb, Saladax Expand Companion Dx Deal to Include Ortho-Clinical Diagnostics

NEW YORK (GenomeWeb News) – Bristol Myers-Squibb and Saladax Biomedical today expanded an agreement covering companion diagnostics to include Johnson & Johnson's Ortho-Clinical Diagnostics.

The three firms will collaborate to develop and gain regulatory approval of certain diagnostic assays. Saladax and Ortho-Clinical have a separate agreement to commercialize assays resulting from the deal.

Financial and other terms of both deals were not disclosed.

Saladax and Bristol-Myers Squibb originally reached a partnership in May 2010 to develop clinical diagnostic tests for certain drug compounds in Bristol Myers-Squibb's pipeline. The terms of that deal called for the two firms to collaborate on development and regulatory approvals.

Saladax had exclusive global rights to commercialize assays developed from the collaboration.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.